WORK WITH US
Commercialization support built for your unique role and stage.
Founders, investors, and programs building toward healthcare innovation face different versions of the same question: is this company ready for what’s next?
Every engagement follows the same path: Assess. Prioritize. Activate.
Choose Your Path.
Each page linked below lays out the three steps, what you get, and how to get started.
FOR FOUNDERS
Pressure-test your next move.
Are we ready for the raise, pitch, or partnership we’re planning? Which opportunity should we pursue first?
Assess: Founder Readiness Session
Prioritize: Commercial Strategy Deep Dive
Activate: Commercialization Activation
Explore founder options.
FOR FOUNDERS & EXECUTIVE TEAMS
Founders rarely hear a clear no.
More often, they hear: “Too early.” “Not in our thesis.” “Come back when you have traction.”
Without a shared readiness standard, that feedback is hard to operationalize. Teams continue building, but sequencing risk goes unnamed.
Commercialization and adoption risk are often deferred behind product, regulatory, or capital milestones. When they surface, correction is costly and credibility is already on the line.
THE FRICTION
We bring a structured readiness standard to your growth strategy.
The MCG Framework and Scorecard identify sequencing gaps early and translate feedback into clear execution priorities.
Where capabilities fall short, we work alongside leadership to close gaps before capital and market scrutiny intensify.
HOW MCG SOLVES IT
Phase-based Commercial Readiness assessment
Sequencing and commercialization roadmap
GTM and access alignment strategy
Advisory support during inflection points and fundraising cycles
WHAT WE PROVIDE
INVESTOR FEEDBACK ON THE MCG COMMERCIAL READINESS FRAMEWORK
“The way it [the Framework] surfaces misalignment between scientific progress, capital expectations, and execution realities maps closely to what we see in diligence and post-investment.”
— Private Equity Healthcare Investor“This is an insightful document, and the experience of those who built it is quite evident in the roadmap. Companies rarely map these steps perfectly. It's a good guide and provoked thought on my part.”
— Series B Medtech Founder & CEO“Commercial readiness is one of the biggest unmet needs in early-stage healthcare. The hard part is helping founders see it before investors do.”
— Venture Capital Healthcare Investor
